& Bracci-Laudiero, L
Laboratory data indicate that GHK-Cu may affect extracellular-matrix-related readouts in cultured cells and animal research models
Elevated TMAO levels are linked to atherosclerosis, oxidative stress, and an increased risk of cardiovascular disease, diabetes, and chronic kidney disease
Short-acting GLP-1RAs, such as lixisenatide, maintain robust effects on gastric emptying, whereas long-acting agents, like liraglutide and semaglutide, exhibit reduced efficacy due to continuous receptor activation
Retail pharmaceutical pricing (Wegovy/Mounjaro as proxies for future retatrutide pricing) runs $1,000-1,400 monthly without insurance, or $12,000-16,800 annually
Breastfeeding and GLP-1 medications Research on GLP-1 medication safety during breastfeeding is very limited